Ministru kabineta 2013. gada 22.janvāra noteikumi Nr.47 "Farmakovigilances kārtība"

These rules establish the procedures for monitoring the safety of medicines once they are on the market. They aim to ensure that any adverse reactions are detected, assessed, and prevented. These regulations affect pharmaceutical companies, healthcare professionals, and patients by outlining responsibilities for reporting and managing drug safety information.